Nuclear Cataract
📧 Sign up to get email alerts when something new happens for Nuclear Cataract.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-11-10Clinical Trial Update: The Impact of Physiologic Cataract Surgery on Patient Comfort and Medication Usage [NA]
This clinical trial is exploring whether physiologic cataract surgery affects patient comfort and medication usage and is not yet recruiting…
-
CLINICAL_TRIALS trial_result · 2025-05-21Clinical Trial Update: Less Discomfort and Less Pharmacology. Cataract Surgery at Physiologic Intraocular Pressure (IOP)
A completed clinical trial evaluating cataract surgery performed at physiologic intraocular pressure to reduce patient discomfort and pharma…
-
CLINICAL_TRIALS trial_result · 2025-03-11Clinical Trial Update: The Comparison of Cataract Lasers Using the Optimedica Catalys Laser and the Alcon LenSx Laser. [NA]
A completed clinical trial comparing the Optimedica Catalys laser and the Alcon LenSx laser for cataract surgery.
-
CLINICAL_TRIALS trial_result · 2024-04-16Clinical Trial Update: The Safety and Efficacy Study of Ethylenediaminetetraacetic Acid (EDTA) Ophthalmic Solution in Patients With Loss of Contrast Sensitivity Due to Age-Related, Low-Grade Nuclear Cataract [Phase 1, Phase 2]
Clinical trial update on EDTA ophthalmic solution for age-related cataracts, focusing on safety and efficacy in patients with low-grade nucl…
-
CLINICAL_TRIALS trial_result · 2015-12-04Clinical Trial Update: The Post-Vitrectomy Lenstatin™ Study [NA]
The post-vitrectomy Lenstatin study for nuclear cataract has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2009-01-21Clinical Trial Update: Dose-Ranging Study of an Ophthalamic Solution in Patients With Loss of Visual Function Due to Age-Related Nuclear Cataract [Phase 2]
Phase 2 dose-ranging trial evaluating an ophthalmic solution for loss of visual function due to age-related nuclear cataract.
-
CLINICAL_TRIALS withdrawal · 2008-04-02Clinical Trial Update: Study of OT-551 Eye Drops to Prevent or Delay Progression of Nuclear Cataracts Following Vitreous Removal [Phase 2]
Phase 2 study of OT-551 Eye Drops to prevent or delay progression of nuclear cataracts after vitrectomy has been terminated.
-
CLINICAL_TRIALS research · 2008-03-04Clinical Trial Update: Cataract Surgery to Obtain Human Lens Material for the Study of Nuclear Cataracts
A completed clinical trial update describing cataract surgery to obtain human lens material for the study of nuclear cataracts.